Schizophrenia. Schizophrenia
Conditions
Interventions
Intervention 1: Intervention group: The intervention group received 5 mg folic acid tablets for six weeks. Symptom severity was evaluated according to PANSS criteria at baseline and weeks 2, 4, and 6.
Sponsors
Gorgan University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Schizophrenia Diagnosis Based on V-DSM Diagnostic Criteria Absence of Extrapyramidal Symptoms Male Gender Age Between 18 to 50 Years Old Completing Informed Consent to Participate in the Study
Exclusion criteria
Exclusion criteria: Clinically Prominent Neurological or Organic Disease Presence of Another Major I-Axis Diagnosis Based on V-DSM Abnormality in Previous Tests IQ Less than 70 Based on Standardized Tests History of Drug Use (Excluding Nicotine and Caffeine) ECT in the Past Two Weeks Oral Antipsychotics in the Past Week or Long-Acting Antipsychotics in the Past Month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reducing Negative Symptoms. Timepoint: Before the intervention and after 6 weeks of drug use. Method of measurement: With PANSS test questionnaire, the process of improvement and reduction of symptoms is measured. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElahe Mehdi Zade
Gorgan University of Medical Sciences
Outcome results
None listed